To clarify how the combination of l-fuc and anti-PD1 therapy enhanced suppression, we characterized immune cell profiles in the tumors and lymph nodes of SM1 tumor-bearing mice over a time course of treatment with l-fuc, with or without anti-PD1 therapy. The gene discussed is PDCD1; the disease is neoplasm.